Tag Archives: 2012 BIO International Convention

We came across this recent post in Boston.com about the BIO International Convention and BIO Business Forum. It’s not just a recap of the event, but it’s a specific piece on one company’s goals, connecting Boston with the Netherlands. As you know, the BIO One-on-One Partnering System is open and accessible to attendees well after the conference shuts down and everyone goes home. This allows you to do your follow-up: go through your Inbox, research Read More >

India’s biotechnology sector is a burgeoning one, with more than 325 companies and some with revenues in the billions of dollars. According to the BioSpectrum-ABLE (Association of Biotechnology Led Enterprises) Biotech Industry Survey of 2011, the industry has grown by 21.5% in 2006-2011, surging to $4 billion. Furthermore, India is the world’s largest manufacturer of vaccines and the growth of India vaccine makers arises from their ability to develop and produce high-quality vaccines with low Read More >

The 2012 BIO International Convention, the global event for biotechnology, held at the Boston Convention & Exhibition Center in Boston, Mass., wrapped this June. The event hosted a record 25,291 partnering meetings and highlighted a broad array of top-level speakers addressing critical global challenges and the top issues in biotechnology. Hosted by the Biotechnology Industry Organization (BIO), the event drew 16,505 industry leaders from 49 states and 65 countries. See what BIO President and CEO Jim Greenwood Read More >

One of our scheduled keynote speakers at the 2012 BIO International Convention in Boston was Senator John Kerry of Massachusetts. Unfortunately the Senator was unable to join us as planned when his duties kept him in Washington, DC for votes on important legislation. Senator Kerry has been a strong supporter of biomedical innovation. During the health care reform debate, Senator Kerry strongly supported and fought for a 12-year data exclusivity period for innovative biomedicines and Read More >

Each year, approximately 1.7 million children die from a vaccine-preventable disease, and the vast majority of these deaths occur in developing countries. This BIO 2012 session, moderated by Peg Willingham of the United Nations Foundation, addressed various ways industry can help increase access to life-saving vaccines for children and adults in resource-poor countries. The thoughts of a few of the speakers on the panel for this session are summarized below. The panelists suggested that for Read More >